In the present work, a new synthetic method toward a key intermediate in the total synthesis of alkannin and shikonin is developed. The key intermediate, 4-methyl-1-(naphtho[1,8-de:4,5-d’e’]bis([1,3]dioxine)-4-yl)pent-3-en-1-one (5), is synthesized via the reaction of 1,8:4,5-bis(methylenedioxy)naphthalene-2-carboxylic acid N-methoxy-N-methylamide with prenyllithium. This synthetic approach avoids the use of N-methoxy-N,4-dimethylpent-3-enamide, which is not easy to obtain, and the toxic reagent sodium cyanide.
Alkannin (1) and shikonin (2) (Figure 1) and their derivatives are naturally occurring purple pigments found in the roots of many traditional medicinal plants of the Boraginaceae family such as Alkanna tinctoria, Lithospermum erythrorhizon, Arnebia hispidissima, and Echium lycopsis.1 Alkannin and shikonin are enantiomers. These compounds show a wide range of significant pharmacological activities, such as antibacterial,2 anti-inflammatory,3 antifungal,4 and antitumor.5–8 Many methodologies on their total synthesis have been described.9–12 Nicolaou13 reported a concise and efficient total synthesis of alkannin and shikonin, in which a novel protecting system for the masking of 5,8-dihydroxy-1,4-naphthoquinones was used and 4-methyl-1-(naphtho[1,8-de:4,5-d’e’]bis([1,3]dioxine)-4-yl)pent-3-en-1-one (5) (Scheme 1) served as a key intermediate. Compound 5 was synthesized using 1,8:4,5-bis(methylenedioxy)naphthalene (3) as the staring material. Monobromination of compound 3 with N-bromosuccinimide (NBS) afforded compound 4 in 70% yield. Halogen–metal exchange at low temperature using tBuLi followed by addition of the Weinreb amide, which was synthesized from a known carboxylic acid precursor by a standard procedure in 61% yield, afforded compound 5 in 63% yield. Asymmetric reduction of compound 5 with (+)-diisopinocampheylchloroborane [(+)-DIP-Cl] and (−)-DIP-Cl afforded compounds 6 and 7, respectively, in yields of 93% and over 98% enantiomeric excesses. Deprotection of compounds 6 and 7 through anodic oxidation afforded alkannin (1) and shikonin (2) in 80% yield at ca. 50% conversion. The asymmetric reduction of compound 5 followed by a one-step deprotection allowed easy and efficient access to alkannin and shikonin. However, the Weinreb amide (N-methoxy-N,4-dimethylpent-3-enamide) used for the synthesis of compound 5 was not easy to obtain. Kim and co-workers14 used another method to synthesize compound 5; however, the toxic reagent sodium cyanide (NaCN) was used in their synthetic route (Scheme 2).
Structures of alkannin (1) and shikonin (2).
Nicolaou’s synthetic route toward alkannin and shikonin. Reagents and conditions: (a) NBS, CHCl3, 25 °C, 12 h, 70%; (b) t-BuLi, THF, −78 °C, 1 h; then N-methoxy-N,4-dimethylpent-3-enamide, −78 °C, 1.5 h, 63%; (c) (+)-DIP-Cl, THF, −40 to 25 °C, 3 h, then CH3CHO, 0 °C, 12 h, 93%, ⩾98% ee; (d) (−)-DIP-Cl, THF, −40 to 25 °C, 3 h, then CH3CHO, 0 °C, 12 h, 93%, ⩾98% ee; and (e) anodic oxidation, CH3CN/H2O (1:1), LiClO4, graphite electrodes, undivided cell, 3 V constant external voltage, 25 °C, 80% at ca. 50% conversion.
Kim’s synthetic route to compound 5. Reagents and conditions: (a) NaCN, H2O, AcOH, THF; (b) ethyloxyethylene, p-TsOH, CH2Cl2, 64%; and (c) LDA, prenyl bromide, 5% H2SO4, MeOH, 85%.
Herein, we report a new procedure for the synthesis of 4-methyl-1-(naphtho[1,8-de:4,5-d’e’]bis([1,3]dioxine)-4-yl)pent-3-en-1-one (5) (Scheme 3).
A new synthetic route to compound 5.
Results and discussion
Compound 5 was synthesized in four steps starting from 1,8:4,5-bis(methylenedioxy)naphthalene (3) (Scheme 3). Compound 3 was acetylated by Friedel–Crafts acylation with acetyl chloride in the presence of AlCl3 to afford 2-acetyl-1,8:4,5-bis(methylenedioxy)naphthalene (10) in 94% yield.15 Compound 10 was then oxidized by tetrabutyl ammonium permanganate in pyridine to afford 1,8:4,5-bis(methylenedioxy)naphthalene-2-carboxylic acid (11) in 88% yield.16 The synthesis of compound 11 from compound 3 was also reported in the literature via a different method;15 however, 11 was obtained in a lower yield of 45% via this method. Treatment of compound 11 with oxalyl chloride in dichloromethane afforded the corresponding acyl chloride.17 Subsequent treatment of this acyl chloride with N,O-dimethyl hydroxylamine hydrochloride in the presence of pyridine in dichloromethane afforded 1,8:4,5-bis(methylenedioxy)naphthalene-2-carboxylic acid N-methoxy-N-methylamide (12) in 79% yield.18 The addition of prenyllithium to compound 12 afforded the desired compound 5 and 3,3-dimethyl-1-(naphtho[1,8-de:4,5-d’e’]bis([1,3]dioxine)-4-yl)but-3-en-1-one (13) in 45% and 47% yield, respectively. Compound 5 is more polar than compound 13, and they were separated by column chromatography. The formation of compound 13 may be ascribed to the fact that the prepared prenyllithium exists a mixture of isomers (Scheme 4). The selectivity for compound 5 may be improved using other allylic organometallic compounds such as prenylmagnesium bromide.
Isomers of prenyllithium.
Conclusion
A new synthetic method toward 4-methyl-1-(naphtho[1,8-de:4,5-d’e’]bis([1,3]dioxine)-4-yl)pent-3-en-1-one (5) has been developed. Compound 5 was synthesized from compound 3 in four steps with an overall yield of 29%. This synthetic approach avoids the use of N-methoxy-N,4-dimethylpent-3-enamide, which is not easy to obtain, as well as the toxic reagent sodium cyanide.
Experimental section
Materials
Compound 3 was synthesized according to a literature method.15 All other chemicals were of analytical grade and were used as received.
A mixture of 1,8:4,5-bis-(methylenedioxy)naphthalene (3) (2.16 g, 10.0 mmol) and anhydrous aluminum chloride (2.70 g, 20.2 mmol) in chloroform (50 mL) was added dropwise to acetyl chloride (0.9 g, 12.6 mmol), and the resulting mixture was stirred at room temperature for 3 h. When the reaction was complete, the mixture was poured into ice-water (30 g), 10% hydrochloric acid (30 mL) was added, and the mixture was filtered. The residue was recrystallized from petroleum ether to give compound 10 as light yellow crystals (2.42 g, 94%). M.p. 168–170 °C. 1H NMR (400 MHz, CDCl3): δ 7.35 (s, 1H, ArH), 6.98 (d, 1H, J = 8.0 Hz, ArH), 6.92 (d, 1H, J = 8.0 Hz, ArH), 5.63 (s, 2H, –OCH2O–), 5.50 (s, 2H, –OCH2O–), and 2.73 (s, 3H, –CH3). 13C NMR (100 MHz, CDCl3): δ 202.3, 144.1, 142.8, 142.4, 141.7, 121.5, 120.6, 114.8, 106.6, 104.3, 101.5, 91.7, and 26.8. HRMS (EI): m/z [M + H]+ calcd for C14H11O5: 259.0606; found: 259.0594.
Tetrabutylammonium permanganate (6.8 g, 18.9 mmol) was added to a solution of compound 10 (2.16 g, 10.0 mmol) in pyridine (60 mL) and the mixture was stirred at room temperature for 24 h under a nitrogen atmosphere. The reaction mixture was poured into 15% hydrochloric acid (250 mL) containing sodium hydrogen sulfite (5.0 g, 48.1 mmol) and extracted with chloroform (100 mL × 4). The chloroform solution was washed with 10% hydrochloric acid (100 mL × 2), and brine (70 mL × 2), dried over anhydrous sodium sulfate, and concentrated. The crude product was chromatographed on silica gel to give compound 11 as yellow crystals (2.14 g, 88%). M.p. 258–260 °C (lit.15 m.p. 258–261 °C). 1H NMR (400 MHz, CDCl3): δ 7.47 (s, 1H, ArH), 7.02-7.00 (m, 2H, ArH), 5.68 (s, 2H, –OCH2O–), and 5.53 (s, 2H, –OCH2O–).
To a solution of compound 11 (1.24 g, 4.61 mmol) and N,N-dimethylformamide (two drops) in dichloromethane (10 mL) cooled in an ice-bath, oxalyl chloride was added dropwise (0.85 g, 10.0 mmol) over 10 min. The mixture was stirred at 0 °C for 30 min, and then allowed to warm to 20 °C for 3 h. The solvent and excess oxalyl chloride were removed in vacuo to give the corresponding acyl chloride. The acyl chloride in dichloromethane (10 mL) was cooled in an ice-bath and added dropwise to a mixture of N,O-dimethylhydroxylamine hydrochloride (0.9 g, 9.3 mmol) and pyridine (0.8 g, 10.1 mmol) in dichloromethane (15 mL) and stirred at 0 °C for 2 h under a nitrogen atmosphere. The reaction mixture was poured into ice-water (30 g) and extracted with dichloromethane (100 mL × 2). The dichloromethane solution was washed with 5% hydrochloric acid (30 mL × 2), and water (30 mL × 2), dried over anhydrous sodium sulfate, and concentrated. The crude product was chromatographed on silica gel to give compound 12 as white crystals (1.07 g, 79%). M.p. 124–126 °C. 1H NMR (400 MHz, CDCl3): δ 6.89 (s, 1H, ArH), 6.85 (s, 2H, ArH), 5.53 (s, 2H, –OCH2O–), 5.51 (s, 2H, –OCH2O–), 3.60 (s, 3H, –NCH3), and 3.36 (s, 3H, –OCH3). 13C NMR (100 MHz, CDCl3): δ 169.5, 143.8, 142.6, 142.3, 141.5, 120.9, 120.4, 111.2, 106.0, 104.3, 102.9, 91.6, 91.2, 63.7, and 33.4. HRMS (EI): m/z [M + H]+ calcd for C15H14NO6: 304.0821; found: 304.0812.
A solution of phenyl γ,γ-dimethylallyl ether (2.0 g, 125 mmol) in dry THF (15 mL) was added dropwise to a stirred suspension of freshly cut lithium pieces (1.5 g, 220 mmol) in dry THF (25 mL) under nitrogen at room temperature. After stirring for 2 h, a deep red color developed, and stirring was continued for an addition 1 h to give the prenyllithium solution.
A solution of compound 12 (0.9 g, 3.0 mmol) in dry THF (30 mL) was cooled to −78 °C, and added dropwise to the above prenyllithium solution over 1 h under nitrogen. The resulting mixture was stirred at −78 °C for 6 h. When the reaction was complete, a saturated aqueous solution of NH4Cl (20 mL) was added to the reaction mixture. The solution was diluted with ethyl acetate and the organic phase was treated with a solution of 10% sodium hydroxide (35 mL × 2), washed with water (20 mL × 2), dried over magnesium sulfate, and concentrated under vacuo. The residue was purified by column chromatography (eluent:petroleum ether/ethyl acetate = 20:1, v/v) to afford compound 5 as pale yellow crystals (0.42 g, yield 45%). M.p. 106–111 °C (lit.13 m.p. 110–114 °C). 1H NMR (400 MHz, CDCl3): δ 7.32 (s, 1H, ArH), 6.97 (d, 1H, J = 7.0 Hz, ArH), 6.93 (d, 1H, J = 7.0 Hz, ArH), 5.61 (s, 2H, –OCH2O–), 5.50 (s, 2H, –OCH2O–), 5.48-5.42 (m, 1H, CH=C), 3.82 (d, 2H, J = 6.8 Hz, –CH2–), 1.77 (s, 3H, –CH3), and 1.68 (s, 3H, –CH3). 13C NMR (100 MHz, CDCl3): δ 197.0, 145.8, 145.6, 144.6, 144.1, 135.3, 119.3, 117.1, 116.3, 115.0, 111.9, 110.1, 107.7, 91.8, 91.4, 43.5, 25.9, and 18.3. HRMS (EI): m/z [M + H]+ calcd for C18H17O5: 313.1076; found: 313.1068. 3,3-Dimethyl-1-(naphtho[1,8-de:4,5-d’e’]bis([1,3]dioxine)-4-yl)but-3-en-1-one (13) was also obtained (0.44 g, 47%). M.p. 96–98 °C. 1H NMR (400 MHz, CDCl3): δ 6.92-6.83 (m, 2H, ArH), 6.79 (s, 1H, ArH), 6.07 (dd, 1H, J = 17.2 Hz, 10.8 Hz, =CH), 5.50 (s, 2H, –OCH2O–), 5.49 (s, 2H, –OCH2O–), 5.17 (dd, 1H, J = 17.2 Hz, J = 0.8 Hz, =CH2a), 5.15 (dd, 1H, J = 10.8 Hz, J = 0.8 Hz, =CH2b), 1.38 (s, 6H, 2× –CH3). 13C NMR (100 MHz, CDCl3): δ 207.1, 145.2, 144.6, 143.8, 142.4, 141.0, 121.9, 115.6, 114.9, 114.6, 110.2, 109.9, 107.3, 92.0, 91.8, 51.6, and 24.5. HRMS (EI): m/z [M + H]+ calcd for C18H17O5: 313.1076; found: 313.1063.
Footnotes
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported by a grant from the Leader Talents of High-level Entrepreneurial and Innovative Talent Team of Jiangsu Province (grant no. 2017-37).
ORCID iD
Defeng Xu
References
1.
PapageorgiouVPAssimopoulouANCouladourosEA, et al. Angew Chem Int Ed 1999; 38: 270–301.
2.
LeeYSLeeDYKimYB, et al. Evid Based Complement Alternat Med2015; 2015: 520578.
3.
ChenXOppenheimJHowardOMZ. Int Immunopharmacol2001; 1: 229–236.
4.
LiaoZYanYDongH, et al. Emerg Microbes Infect2016; 5: e88.
5.
ZhangGZhaiNZhangX.BioFactors2020; 46: 849–859.
6.
ChangMWangHNiuJ, et al. Front Pharmacol2020; 11: 610205.
7.
LuBGongXWangZ, et al. Acta Pharmacol Sin2017; 38: 1543–1553.
8.
WangWWuYChenS, et al. Phytother Res2021; 35: 463–476.
9.
ZhangJLuQDuanW, et al. Chin Chem Lett2005; 16: 465–467.
10.
CouladourosEAStrongilosATPapageorgiouVP, et al. Chem Eur J2002; 8: 1975–1803.
11.
CouladourosEAPlytaZFStrongilosAT, et al. Tetrahedron Lett1997; 38: 7263–7266.
12.
WangRZhouSJiangH, et al. Eur J Org Chem2012; 2012:1373–1379.
13.
NicolaouKCHepworthD.Angew Chem Int Ed1998; 37: 839–841.